高効力医薬品有効成分(API)の世界市場2021年-2028年:製品別(合成、バイオテクノロジー)、メーカー種類別(社内、外部委託)、医薬品種類別、用途別、地域別

【英語タイトル】High Potency Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Product (Synthetic, Biotech), By Manufacturer Type (In-house, Outsourced), By Drug Type, By Application, By Region, And Segment Forecasts, 2021 - 2028

Grand View Researchが出版した調査資料(GV21OC044)・商品コード:GV21OC044
・発行会社(調査会社):Grand View Research
・発行日:2021年9月30日
・ページ数:140
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥797,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥931,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,199,300見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
グランドビューリサーチ社は、高効力医薬品有効成分(API)の世界市場規模が2028年までに388.4億ドルに達すると予測しています。2021年から2028年までに年平均8.4%成長する見通しです。本市場調査資料では、世界の高効力医薬品有効成分(API)市場を広く調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別(合成、バイオテクノロジー)分析、メーカー種類別(社内、外部委託)分析、医薬品種類別(革新的、ジェネリック)分析、用途別(腫瘍、ホルモン障害、緑内障、その他)分析、地域別分析、競争状況などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・高効力医薬品有効成分(API)の世界市場規模:製品別(合成、バイオテクノロジー)
・高効力医薬品有効成分(API)の世界市場規模:メーカー種類別(社内、外部委託)
・高効力医薬品有効成分(API)の世界市場規模:医薬品種類別(革新的、ジェネリック)
・高効力医薬品有効成分(API)の世界市場規模:用途別(腫瘍、ホルモン障害、緑内障、その他)
・高効力医薬品有効成分(API)の世界市場規模:地域別
・競争状況
【レポートの概要】

High Potency Active Pharmaceutical Ingredients Market Growth & Trends

The global high potency active pharmaceutical ingredients market size is expected to reach USD 38.84 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.4% from 2021 to 2028. The market is driven by an increased focus on targeted therapies and a surge in demand for cancer therapies.

The rising prevalence of cancer is a major factor expected to drive the market for high potency active pharmaceutical ingredients (HPAPIs). According to the WHO, cancer is the second biggest cause of death, causing over 9.6 million deaths in 2018 and the use of tobacco is responsible for 22% of cancer deaths. As per the CDC, the risk factors such as lifestyle changes including smoking, obesity, alcohol consumption, and exposure to UV radiation from the sun or tanning beds have contributed to the overall burden of the disease. Moreover, the cost of cancer care is anticipated to reach USD 174 billion by the end of 2020, which is anticipated to accelerate the market growth.

Increased demand for antiviral drugs such as remdesivir for COVID-19 treatment is fueling the demand for high potency antiviral HPAPIs. The change in supplier dynamics owing to COVID-19 and the increased focus of governments on pharmaceutical raw materials, such as HPAPIs, are driving the market.

Japan and China are among the leading countries with numerous biotech companies involved in the production of HPAPIs. The presence of major companies such as Takeda and Sankyo has boosted the development of biotechnology-derived APIs in these countries. Furthermore, the growth of the biotech segment can be attributed to the high investments in the biotechnology and biopharmaceutical sectors. This allows the innovation of new molecules that aid in the treatment of diseases, such as cancer.

Key players are leveraging various strategies to increase their production capabilities and promote the outreach of their product offerings. For instance, in July 2020, CordenPharma International announced the expansion of its peptide manufacturing unit in Colorado to address the increased demand for peptide APIs. This expansion will enable the company to grow and help in generating increased revenue.

High Potency Active Pharmaceutical Ingredients Market Report Highlights

• In 2020, the synthetic product segment held the largest share of over 70.0% owing to the easy availability of raw materials and highly developed manufacturing systems

• By manufacturer type, the outsourced segment is projected to grow at the fastest rate over the forecast period

• Based on drug type, the innovative segment held the largest revenue share in 2020 owing to the increased focus on R&D

• In terms of application, the oncology segment dominated the HPAPIs market in 2020 owing to the rising incidence of cancer worldwide

• Asia Pacific is expected to witness the fastest growth during the forecast period due to the improving manufacturing infrastructure and the presence of numerous generic HPAPI manufacturing companies

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.2.1 Information procurement
1.3 Information or Data Analysis
1.4 Market Formulation & Validation
1.5 Region-wise Market Calculation
1.5.1 Region-Wise Market: Base Estimates
1.5.2 Global Market: CAGR Calculation
1.6 Region-based Segment Share Calculation
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.8.1 Primary interview breakup
1.8.1.1 Data for primary interviews, by sources
1.8.1.2 Data for primary interviews, by region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 High Potency Active Pharmaceutical Ingredients Market Variables, Trends & Scope
3.1 Market Driver Analysis
3.1.1 Rising prevalence of cancer
3.1.2 Growth of targeted therapies
3.1.3 Increasing application of HPAPIs
3.1.4 Market Restraint Analysis
3.1.4.1 Large investments and very stringent safety and handling specifications associated with the production of HPAPIs
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.4 Regulatory Scenario
3.5 Pricing Analysis
3.6 Impact of generic drugs on the overall market
3.6.1 High Potency Active Pharmaceutical Ingredients – SWOT Analysis, By Factor (political & legal, economic and technological)
3.6.2 Industry Analysis – Porter’s
Chapter 4 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Product, 2017 – 2028 (USD Million)
4.1 Product Market Share Analysis, 2020 & 2028
4.1.1 Synthetic
4.1.1.1 Synthetic market estimates and forecasts, 2017 – 2028 (USD Million)
4.1.2 Biotech
4.1.2.1 Biotech market estimates and forecasts, 2017 – 2028 (USD Million)
Chapter 5 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Manufacturer Type, 2017 – 2028 (USD Million)
5.1 Manufacturer Type Market Share Analysis, 2020 & 2028
5.1.1 In-house
5.1.1.1 In-house market estimates and forecasts, 2017 – 2028 (USD Million)
5.1.2 Outsourced
5.1.2.1 Outsourced market estimates and forecasts, 2017 – 2028 (USD Million)
Chapter 6 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Drug Type, 2017 – 2028 (USD Million)
6.1 Drug Type Market Share Analysis, 2020 & 2028
6.1.1 Innovative
6.1.1.1 Innovative market estimates and forecasts, 2017 – 2028 (USD Million)
6.1.2 Generic
6.1.2.1 Generic market estimates and forecasts, 2017 – 2028 (USD Million)
Chapter 7 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Application, 2017 – 2028 (USD Million)
7.1 Application Market Share Analysis, 2020 & 2028
7.1.1 Oncology
7.1.1.1 Oncology market estimates and forecasts, 2017 – 2028 (USD Million)
7.1.2 Hormonal disorders
7.1.2.1 Hormonal disorders market estimates and forecasts, 2017 – 2028 (USD Million)
7.1.3 Glaucoma
7.1.3.1 Glaucoma market estimates and forecasts, 2017 – 2028 (USD Million)
7.1.4 Other Applications
7.1.4.1 Other applications market estimates and forecasts, 2017 – 2028 (USD Million)
Chapter 8 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Region, 2017 – 2028 (USD Million)
8.1 High Potency Active Pharmaceutical Ingredients Market, Market Share by Region, 2020 & 2028
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2017 – 2028 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2017 – 2028 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2017 – 2028 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2017 – 2028 (USD Million)
8.1.2.2 U.K.
8.1.2.2.1 U.K. market estimates and forecast, 2017 – 2028 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2017 – 2028 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2017 – 2028 (USD Million)
8.1.2.5 Spain
8.1.2.5.1 Spain market estimates and forecast, 2017 – 2028 (USD Million)
8.1.2.6 Italy
8.1.2.6.1 Italy market estimates and forecast, 2017 – 2028 (USD Million)
8.1.2.7 Russia
8.1.2.7.1 Russia market estimates and forecast, 2017 – 2028 (USD Million)
8.1.2.8 Switzerland
8.1.2.8.1 Switzerland market estimates and forecast, 2017 – 2028 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2017 – 2028 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2017 – 2028 (USD Million)
8.1.3.3 China
8.1.3.3.1 China market estimates and forecast, 2017 – 2028 (USD Million)
8.1.3.4 India
8.1.3.4.1 India market estimates and forecast, 2017 – 2028 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2017 – 2028 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2017 – 2028 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2017 – 2028 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2017 – 2028 (USD Million)
8.1.4.5 Colombia
8.1.4.5.1 Colombia market estimates and forecast, 2017 – 2028 (USD Million)
8.1.4.6 Chile
8.1.4.6.1 Chile market estimates and forecast, 2017 – 2028 (USD Million)
8.1.5 Middle East and Africa
8.1.6 Middle East & Africa market estimates and forecast, 2017 – 2028 (USD Million)
8.1.6.1 South Africa
8.1.6.1.1 South Africa market estimates and forecast, 2017 – 2028 (USD Million)
Chapter 9 Competitive Landscape
9.1 Recent developments & impact analysis, by key market participants
9.1.1 Ansoff matrix
9.2 Major deals & strategic alliances analysis
9.2.1 Joint Ventures
9.2.2 Licensing and Partnerships
9.2.3 Technological Collaborations
9.3 Company/Competition Categorization
9.4 Vendor Landscape
9.4.1 List of key distributors and channel partners
9.4.2 Key customers
9.5 Public Companies
9.5.1 Company market position analysis
9.6 Private Companies
9.6.1 List of key emerging companies
9.6.2 Regional Network Map
9.7 Company Profiles
9.7.1 BASF SE
9.7.1.1 Company Overview
9.7.1.2 Financial Performance
9.7.1.3 Product Benchmarking
9.7.1.4 Strategic Initiatives
9.7.2 CordenPharma International
9.7.2.1 Company Overview
9.7.2.2 Product Benchmarking
9.7.2.3 Strategic Initiatives
9.7.3 Dr. Reddy’s Laboratories Ltd.
9.7.3.1 Company Overview
9.7.3.2 Financial Performance
9.7.3.3 Product Benchmarking
9.7.3.4 Strategic Initiatives
9.7.4 Carbogen Amcis AG
9.7.4.1 Company Overview
9.7.4.2 Financial Performance
9.7.4.3 Product Benchmarking
9.7.4.4 Strategic Initiatives
9.7.5 Pfizer Inc.
9.7.5.1 Company Overview
9.7.5.2 Financial Performance
9.7.5.3 Product Benchmarking
9.7.5.4 Strategic Initiatives
9.7.6 Sun Pharmaceutical Industries Ltd.
9.7.6.1 Company Overview
9.7.6.2 Financial Performance
9.7.6.3 Product Benchmarking
9.7.6.4 Strategic Initiatives
9.7.7 Teva Pharmaceutical Industries Ltd.
9.7.7.1 Company Overview
9.7.7.2 Financial Performance
9.7.7.3 Product Benchmarking
9.7.7.4 Strategic Initiatives
9.7.8 Albany Molecular Research Inc.
9.7.8.1 Company Overview
9.7.8.2 Product Benchmarking
9.7.8.3 Strategic Initiatives
9.7.9 Sanofi
9.7.9.1 Company Overview
9.7.9.2 Financial Performance
9.7.9.3 Product Benchmarking
9.7.9.4 Strategic Initiatives
9.7.10 Merck & Co., Inc.
9.7.10.1 Company Overview
9.7.10.2 Financial Performance
9.7.10.3 Product Benchmarking
9.7.10.4 Strategic Initiatives
9.7.11 Novartis AG
9.7.11.1 Company Overview
9.7.11.2 Financial Performance
9.7.11.3 Product Benchmarking
9.7.11.4 Strategic Initiatives
9.7.12 F. Hoffmann-La Roche Ltd.
9.7.12.1 Company Overview
9.7.12.2 Financial Performance
9.7.12.3 Product Benchmarking
9.7.12.4 Strategic Initiatives
9.7.13 Bristol-Myers Squibb Company
9.7.13.1 Company Overview
9.7.13.2 Financial Performance
9.7.13.3 Product Benchmarking
9.7.13.4 Strategic Initiatives
9.7.14 Boehringer Ingelheim GmbH
9.7.14.1 Company Overview
9.7.14.2 Financial Performance
9.7.14.3 Product Benchmarking
9.7.14.4 Strategic Initiatives
9.7.15 Lonza
9.7.15.1 Company Overview
9.7.15.2 Financial Performance
9.7.15.3 Product Benchmarking
9.7.15.4 Strategic Initiatives
9.7.16 Cipla Inc.
9.7.16.1 Company Overview
9.7.16.2 Financial Performance
9.7.16.3 Product Benchmarking
9.7.16.4 Strategic Initiatives


List of Tables

TABLE 1 Estimated new cancer case statistics 2016 & 2018
TABLE 2 Global High potency active pharmaceutical ingredients market, by region, 2017 - 2028 (USD Million)
TABLE 3 Global High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 4 Global High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 5 Global High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 6 Global High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 7 North America High potency active pharmaceutical ingredients market, by country, 2017 - 2028 (USD Million)
TABLE 8 North America High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 9 North America High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 10 North America High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 11 North America High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 12 U.S. High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 13 U.S. High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 14 U.S. High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 15 U.S.High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 16 Canada High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 17 Canada High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 18 Canada High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 19 Canada High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 20 Europe High potency active pharmaceutical ingredients market, 2017 - 2028 (USD Million)
TABLE 21 Europe High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 22 Europe High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 23 Europe High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 24 Europe High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 25 U.K. High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 26 U.K. High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 27 U.K. High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 28 U.K. High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 29 Germany High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 30 Germany High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 31 Germany High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 32 Germany High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 33 Spain High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 34 Spain High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 35 Spain High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 36 Spain High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 37 France High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 38 France High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 39 France High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 40 France High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 41 Italy High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 42 Italy High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 43 Italy High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 44 Italy High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 45 Russia High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 46 Russia High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 47 Russia High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 48 Russia High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 49 Switzerland High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 50 Switzerland High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 51 Switzerland High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 52 Switzerland High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 53 Asia Pacific High potency active pharmaceutical ingredients market, 2017 – 2028 (USD Million)
TABLE 54 Asia Pacific High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 55 Asia Pacific High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 56 Asia Pacific High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 57 Asia Pacific High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 58 Japan High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 59 Japan High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 60 Japan High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 61 Japan High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 62 China High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 63 China High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 64 China High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 65 China High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 66 India High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 67 India High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 68 India High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 69 India High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 70 Latin America High potency active pharmaceutical ingredients market, 2017 - 2028 (USD Million)
TABLE 71 Latin America High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 72 Latin America High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 73 Latin America High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 74 Latin America High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 75 Brazil High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 76 Brazil High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 77 Brazil High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 78 Brazil High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 79 Mexico High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 80 Mexico High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 81 Mexico High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 82 Mexico High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 83 Argentina High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 84 Argentina High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 85 Argentina High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 86 Argentina High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 87 Chile High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 88 Chile High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 89 Chile High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 90 Chile High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 91 Colombia High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 92 Colombia High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 93 Colombia High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 94 Colombia High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 95 MEA High potency active pharmaceutical ingredients market, 2017 - 2028 (USD Million)
TABLE 96 MEA High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 97 MEA High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 98 MEA High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 99 MEA High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 100 South Africa High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 101 South Africa High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 102 South Africa High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 103 South Africa High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)

List of Figures

FIG. 1 High Potency Active Pharmaceutical Ingredients (HPAPIs) market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Primary interviews, by sources
FIG. 10 Primary interviews, by region
FIG. 11 High potency active pharmaceutical ingredients market summary
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Estimated number of cancer cases (5 year) worldwide
FIG. 14 New cases of cancer worldwide (2018)
FIG. 15 High potency active pharmaceutical ingredients market restraint impact
FIG. 16 Penetration and growth prospect mapping
FIG. 17 User perspective analysis
FIG. 18 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 19 Porter’s five forces analysis
FIG. 20 High potency active pharmaceutical ingredients product outlook: key takeaways
FIG. 21 High potency active pharmaceutical ingredients market: product movement analysis
FIG. 22 Synthetic market, 2017 - 2028 (USD Million)
FIG. 23 Biotech market, 2017 - 2028 (USD Million)
FIG. 24 High potency active pharmaceutical ingredients market type of manufacturer outlook: Key takeaways
FIG. 25 High potency active pharmaceutical ingredients market: type of manufacturer movement analysis
FIG. 26 In-house market, 2017 - 2028 (USD Million)
FIG. 27 Outsourced market, 2017 - 2028 (USD Million)
FIG. 28 High potency active pharmaceutical ingredients market application outlook: key takeaways
FIG. 29 High potency active pharmaceutical ingredients market: drug type movement analysis
FIG. 30 Innovative market, 2017 - 2028 (USD Million)
FIG. 31 Generic market, 2017 - 2028 (USD Million)
FIG. 32 High potency active pharmaceutical ingredients market application outlook: key takeaways
FIG. 33 High potency active pharmaceutical ingredients market: application movement analysis
FIG. 34 Oncology market, 2017 - 2028 (USD Million)
FIG. 35 Hormonal disorders market, 2017 - 2028 (USD Million)
FIG. 36 Glaucoma market, 2017 - 2028 (USD Million)
FIG. 37 Other applications market, 2017 - 2028 (USD Million)
FIG. 38 Regional marketplace: key takeaways
FIG. 39 Regional outlook, 2020 & 2028
FIG. 40 North America
FIG. 41 North America. market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 42 U.S.
FIG. 43 U.S. market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 44 Canada
FIG. 45 Canada market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 46 Europe
FIG. 47 Europe market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 48 U.K.
FIG. 49 U.K. market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 50 Germany
FIG. 51 Germany market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 52 France
FIG. 53 France market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 54 Spain
FIG. 55 Spain market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 56 Italy
FIG. 57 Italy market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 58 Russia
FIG. 59 Russia market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 60 Switzerland
FIG. 61 Switzerland market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 62 Asia Pacific
FIG. 63 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 64 Japan
FIG. 65 Japan market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 66 China
FIG. 67 China market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 68 India
FIG. 69 India market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 70 Latin America
FIG. 71 Latin America market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 72 Brazil
FIG. 73 Brazil market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 74 Mexico
FIG. 75 Mexico market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 76 Argentina
FIG. 77 Argentina market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 78 Colombia
FIG. 79 Colombia market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 80 Chile
FIG. 81 Chile market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 82 Middle East & Africa
FIG. 83 MEA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 84 South Africa
FIG. 85 South Africa market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 86 Ansoff Matrix
FIG. 87 Strategy mapping
FIG. 88 Company/Competition Categorization
FIG. 89 Heat Map Analysis
FIG. 90 Regional Network Map

★調査レポート[高効力医薬品有効成分(API)の世界市場2021年-2028年:製品別(合成、バイオテクノロジー)、メーカー種類別(社内、外部委託)、医薬品種類別、用途別、地域別] (コード:GV21OC044)販売に関する免責事項を必ずご確認ください。
★調査レポート[高効力医薬品有効成分(API)の世界市場2021年-2028年:製品別(合成、バイオテクノロジー)、メーカー種類別(社内、外部委託)、医薬品種類別、用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆